Trial for in vitro screening of cytotoxic T lymphocyte induction with use of allogeneic dendritic cells for patients with pleural or peritoneal carcinomatosis
Not Applicable
- Conditions
- Peritoneal or pleural carcinomatosis (carcinomas of the stomach, colorectum, biliary duct, pancreas, uterus, ovary, kidney, lung or malignant melanoma etc.) and malignant mesothelioma
- Registration Number
- JPRN-UMIN000001016
- Lead Sponsor
- Division of Gastrointestinal Surgery, Kobe University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1) Active double cancer. 2) Exclude the patients who have serious illness or suspect to have serious illness. 3) Myocardial infarction or unstable angina, occurred within 6 months. 4) Psychosis. 5) Women during pregnancy or breast-feeding. 6) Previous history of severe drug-induced allergy. 7) Exclude the patients who are recognized as inadequate patients by doctors with responsibility in this trial.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Induction rate of cancer-specific cytotoxic T lymphocyte (CTL) in vitro
- Secondary Outcome Measures
Name Time Method Cytotoxic potency or cytokine production of the cancer-specific CT